Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 5, 2024Nature CancerOpen Access

Co-targeting SOS1 enhances the antitumor effects of KRASG12C inhibitors by addressing intrinsic and acquired resistance

View Full Paper
Ask AI
Bookmark
Share

Authors

VTVenu ThatikondaBioScientia (Poland)HLHengyu LyuThe University of Texas MD Anderson Cancer CenterSJSabine JuradoBoehringer Ingelheim (Austria)

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Thatikonda et al. (2024) studied this question.

synapsesocial.com/papers/68e5d57fb6db64358756ba80https://doi.org/10.1038/s43018-024-00800-6
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A transcriptional MAPK Pathway Activity Score (MPAS) is a clinically relevant biomarker in multiple cancer types2018 · 218 citations
  2. 2Single-cell transcriptomics reveals opposing roles of Shp2 in Myc-driven liver tumor cells and microenvironment2021 · 49 citations
  3. 3Fibroblast growth factor receptor 1/Klothoβ agonist BFKB8488A improves lipids and liver health markers in patients with diabetes or NAFLD: A phase 1b randomized trial2022 · 33 citations